联邦制药(03933)：左氧氟沙星滴眼液通过中国国家药品监督管理局上市审批

智通财经2025-12-09

智通财经APP讯，联邦制药(03933)发布公告，本公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的左氧氟沙星滴眼液(规格：0.488%(5ml: 24.4mg))通过中国国家药品监督管理局上市审批，药品批准文号：国药准字H20256135。左氧氟沙星为第三代喹诺酮类抗生素，通过抑制细菌DNA旋转酶和拓扑异构酶IV的活性阻碍细菌DNA的合成，对多种革兰氏阳性菌和革兰氏阴性菌具有显著抗菌活性...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2590831422?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-09 17:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590831422","market":"fut","top_or_hot":-1,"title":"联邦制药(03933)：左氧氟沙星滴眼液通过中国国家药品监督管理局上市审批","media":"智通财经","content":"<div>\n<p>智通财经APP讯，联邦制药(03933)发布公告，本公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的左氧氟沙星滴眼液(规格：0.488%(5ml: 24.4mg))通过中国国家药品监督管理局上市审批，药品批准文号：国药准字H20256135。左氧氟沙星为第三代喹诺酮类抗生素，通过抑制细菌DNA旋转酶和拓扑异构酶IV的活性阻碍细菌DNA的合成，对多种革兰氏阳性菌和革兰氏阴性菌具有显著抗菌活性...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1379399.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>联邦制药(03933)：左氧氟沙星滴眼液通过中国国家药品监督管理局上市审批</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n联邦制药(03933)：左氧氟沙星滴眼液通过中国国家药品监督管理局上市审批\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-09 17:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1379399.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，联邦制药(03933)发布公告，本公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的左氧氟沙星滴眼液(规格：0.488%(5ml: 24.4mg))通过中国国家药品监督管理局上市审批，药品批准文号：国药准字H20256135。左氧氟沙星为第三代喹诺酮类抗生素，通过抑制细菌DNA旋转酶和拓扑异构酶IV的活性阻碍细菌DNA的合成，对多种革兰氏阳性菌和革兰氏阴性菌具有显著抗菌活性...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1379399.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03933","symbol_name":"联邦制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1379399.html","article_id":"2590831422","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590831422","pubTimestamp":1765274063,"columns":[{"name":"产品发布","id":31,"label_key":"productRelease"}],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，联邦制药 发布公告，本公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的左氧氟沙星滴眼液通过中国国家药品监督管理局上市审批，药品批准文号：国药准字H20256135。现时，左氧氟沙星滴眼液为国家医保目录甲类药品。本次获批将进一步拓展联邦制药眼科产品布局，强化本公司于眼科抗感染治疗领域的优势地位。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"03933":"联邦制药","BK1191":"制药"},"translate_title":"United Laboratories (03933): Levofloxacin Eye Drops Passed Marketing Approval from China National Medical Products Administration","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03933":1.5},"content_text":"智通财经APP讯，联邦制药(03933)发布公告，本公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的左氧氟沙星滴眼液(规格：0.488%(5ml: 24.4mg))通过中国国家药品监督管理局上市审批，药品批准文号：国药准字H20256135。左氧氟沙星为第三代喹诺酮类抗生素，通过抑制细菌DNA旋转酶和拓扑异构酶IV的活性阻碍细菌DNA的合成，对多种革兰氏阳性菌和革兰氏阴性菌具有显著抗菌活性。左氧氟沙星滴眼液具有抗菌谱广、抗菌作用强等特点，其临床应用广泛，可用于眼睑炎、睑腺炎、泪囊炎、结膜炎、睑板腺炎、角膜炎的治疗及眼科围手术期的无菌化疗法。现时，左氧氟沙星滴眼液为国家医保目录(2024年版)甲类药品。本次获批将进一步拓展联邦制药眼科产品布局，强化本公司于眼科抗感染治疗领域的优势地位。本公司将持续致力于推进新产品研发，为临床提供全面、优质的用药解决方案，预期将为本公司及其股东创造更大收益。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590831422","isCrawlerRequest":true}